Patient-Perceived Overall Side Effect Bother at and After Cancer Treatment Discontinuation: An Analysis Using Commercial Cancer Trial Data

20260 citationsJournal Articlehybrid Open Access

Authors

Jessica Roydhouse · University of Tasmania

Monique Breslin · University of Tasmania

Anne Rose Zola · Northwestern University

Ethan Basch · University of North Carolina at Chapel Hill

Melanie Calvert · NIHR Birmingham Biomedical Research Centre

David Cella · Northwestern University

Mary Lou Smith

Abstract

Persistent side effect bother and symptomatic and functional detriments at and after discontinuation suggest capturing this information post-treatment can inform understanding of tolerability, particularly with improved PRO completion.

Topics & Keywords

Cancer Treatment and Pharmacology Cancer survivorship and care Pain Management and Placebo Effect

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Therapeutic Innovation & Regulatory Science

Volume 60, Issue 2, pp. 575-590

DOI: 10.1007/s43441-025-00906-8

Field-Weighted Citation Impact: 0.00